U.S. FDA Approves Navidea Biopharmaceuticals' Lymphoseek® (technetium Tc 99m tilmanocept) Injection for Expanded Use

Press releases may be edited for formatting or style | June 16, 2014

Source: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals
Brent Larson, 614-822-2330

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

Executive VP & CFO

or

Sharon Correia, 978-655-2686
Associate Director, Corporate Communications

Back to HCB News



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!